跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要研究遗传集合关联检验,提及基因网络不足以归入经济网络与干扰等所列计量细分。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Ryan Sun
Xihong Lin

基于广义Berk–Jones统计量的遗传变异集合检验及乳腺癌应用

研究问题
当遗传变异集合中的效应较弱、变量相关且信号稀疏程度不同,如何检验整个集合与疾病结果的关联?
方法与思路
作者提出考虑SNP相关性的广义Berk–Jones检验,给出有限集合的解析p值计算,并构造适应不同稀疏程度的综合统计量。
材料陈述的贡献
摘要称方法可使用单个SNP的GWAS汇总统计量;在中等稀疏信号下具有比较优势,并在乳腺癌应用中发现关联证据。
阅读关注点
应核对SNP相关结构如何获得、解析p值的适用条件、稀疏度比较设置,以及基因关联结果的多重检验处理。
阅读边界
仅据版本未注明的OpenAlex摘要,比较优势的条件与数值幅度未完整说明;遗传关联证据不能直接解释为因果效应。

原文摘要

Studying the effects of groups of single nucleotide polymorphisms (SNPs), as in a gene, genetic pathway, or network, can provide novel insight into complex diseases like breast cancer, uncovering new genetic associations and augmenting the information that can be gleaned from studying SNPs individually. Common challenges in set-based genetic association testing include weak effect sizes, correlation between SNPs in a SNP-set, and scarcity of signals, with individual SNP effects often ranging from extremely sparse to moderately sparse in number. Motivated by these challenges, we propose the Generalized Berk-Jones (GBJ) test for the association between a SNP-set and outcome. The GBJ extends the Berk-Jones statistic by accounting for correlation among SNPs, and it provides advantages over the Generalized Higher Criticism test when signals in a SNP-set are moderately sparse. We also provide an analytic p-value calculation for SNP-sets of any finite size, and we develop an omnibus statistic that is robust to the degree of signal sparsity. An additional advantage of our work is the ability to conduct inference using individual SNP summary statistics from a genome-wide association study (GWAS). We evaluate the finite sample performance of the GBJ through simulation and apply the method to identify breast cancer risk genes in a GWAS conducted by the Cancer Genetic Markers of Susceptibility Consortium. Our results suggest evidence of association between FGFR2 and breast cancer and also identify other potential susceptibility genes, complementing conventional SNP-level analysis.

笔记与分组